[The effect of cardiovascular agents on amino acid aryl amidase].
D000404:Ajmaline / Q000009:adverse effects; D000409:Alanine; D000577:Amides; D000619:Aminohydrolases / Q000097:blood*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001391:Azo Compounds; D002301:Cardiac Glycosides / Q000009:adverse effects*; D006801:Humans; D011433:Propranolol / Q000009:adverse effects*; D011802:Quinidine / Q000009:adverse effects; D011817:Rabbits; D013328:Strophanthins / Q000009:adverse effects
D000577:Amides; D000889:Anti-Arrhythmia Agents; D001391:Azo Compounds; D002301:Cardiac Glycosides; D013328:Strophanthins; D000404:Ajmaline; D011433:Propranolol; D000619:Aminohydrolases; D011802:Quinidine; D000409:Alanine
Uber die Beeinflussung der Aminosäurearylamidase durch herzwirksame Pharmaka.